P3 Health Partners Inc.
PIII
$2.74
-$0.34-11.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.68% | -3.29% | 3.00% | 8.54% | 17.15% |
| Total Other Revenue | 78.61% | -- | -- | -- | -- |
| Total Revenue | -2.76% | -2.15% | 4.20% | 9.79% | 18.48% |
| Cost of Revenue | -2.57% | -0.88% | 10.14% | 16.39% | 26.29% |
| Gross Profit | -2.11% | -45.42% | -944.38% | -397.63% | -286.24% |
| SG&A Expenses | -0.46% | -9.89% | -10.57% | -8.28% | -14.23% |
| Depreciation & Amortization | -2.20% | -2.56% | -1.88% | -1.27% | -0.71% |
| Other Operating Expenses | -65.08% | -89.84% | 336.79% | 371.51% | 522.65% |
| Total Operating Expenses | -4.29% | -2.17% | 12.00% | 17.82% | 25.97% |
| Operating Income | 11.78% | 2.33% | -75.15% | -84.52% | -82.46% |
| Income Before Tax | -4.92% | -11.79% | -75.71% | -68.41% | -66.54% |
| Income Tax Expenses | -53.84% | 566.97% | -15.67% | -24.32% | 62.78% |
| Earnings from Continuing Operations | -4.09% | -14.45% | -73.13% | -66.15% | -66.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.35% | 5.30% | 50.86% | 43.92% | 35.66% |
| Net Income | -8.91% | -27.61% | -110.10% | -104.58% | -135.14% |
| EBIT | 11.78% | 2.33% | -75.15% | -84.52% | -82.46% |
| EBITDA | 15.52% | 2.20% | -152.12% | -182.01% | -171.17% |
| EPS Basic | 12.69% | -25.62% | -78.59% | -71.31% | -59.32% |
| Normalized Basic EPS | -37.43% | -186.41% | -668.49% | -475.10% | -139.77% |
| EPS Diluted | -13.76% | 15.88% | -11.90% | -20.74% | -16.32% |
| Normalized Diluted EPS | -73.53% | -194.56% | -794.57% | -531.41% | -140.08% |
| Average Basic Shares Outstanding | 22.44% | 13.82% | 24.71% | 26.81% | 41.07% |
| Average Diluted Shares Outstanding | 87.29% | 12.28% | -11.68% | -10.54% | -6.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |